Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $10.90 and last traded at $10.71, with a volume of 278832 shares traded. The stock had previously closed at $10.64.
Cybin Stock Performance
The stock has a 50 day moving average of $9.55 and a two-hundred day moving average of $3.55. The firm has a market capitalization of $1.59 billion and a P/E ratio of -44.33.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
- Five stocks we like better than Cybin
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- How to Use Stock Screeners to Find Stocks
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What to Know About Investing in Penny Stocks
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
